Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2004 1
2010 2
2012 1
2014 1
2018 1
2019 2
2022 2
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Nasopharyngeal squamous cell carcinoma: a comparative analysis of keratinizing and nonkeratinizing subtypes.
Vazquez A, Khan MN, Govindaraj S, Baredes S, Eloy JA. Vazquez A, et al. Int Forum Allergy Rhinol. 2014 Aug;4(8):675-83. doi: 10.1002/alr.21332. Epub 2014 Apr 14. Int Forum Allergy Rhinol. 2014. PMID: 24733735
BACKGROUND: Nasopharyngeal squamous cell carcinoma (NPSCC) is uncommon in non-endemic regions. ...
BACKGROUND: Nasopharyngeal squamous cell carcinoma (NPSCC) is uncommon in non-endemic regions. ...
Current thinking on the management of abnormal retropharyngeal nodes in patients with oral, oropharyngeal, and nasopharyngeal squamous cell carcinoma: a structured review.
Doumas S, Fort-Schaale A, Skoulakis C, Moor J, Kanatas A. Doumas S, et al. Br J Oral Maxillofac Surg. 2019 Jul;57(6):515-528. doi: 10.1016/j.bjoms.2019.04.017. Epub 2019 May 7. Br J Oral Maxillofac Surg. 2019. PMID: 31076218 Free article. Review.
The management of enlarged retropharyngeal lymph nodes (RLN) in patients with confirmed oral, oropharyngeal, or nasopharyngeal squamous cell carcinoma (SCC) has prognostic relevance and is a challenge for the clinical teams. ...
The management of enlarged retropharyngeal lymph nodes (RLN) in patients with confirmed oral, oropharyngeal, or nasopharyngeal squ
Developing a nomogram model and prognostic analysis of nasopharyngeal squamous cell carcinoma patients: a population-based study.
Liu K, Wang J. Liu K, et al. J Cancer Res Clin Oncol. 2023 Oct;149(13):12165-12175. doi: 10.1007/s00432-023-05120-3. Epub 2023 Jul 10. J Cancer Res Clin Oncol. 2023. PMID: 37428250
BACKGROUND: Nasopharyngeal squamous cell carcinoma (NPSCC) is a common histo-logical subtype of nasopharyngeal cancer with a generally poor prognosis. ...
BACKGROUND: Nasopharyngeal squamous cell carcinoma (NPSCC) is a common histo-logical subtype of nasopharyngeal c …
Prognostic value of the Epstein-Barr virus and tumor suppressor gene p53 gene in nasopharyngeal squamous cell carcinoma.
Liu J, Liu Y, Zhang Z, Sun H, Ji X, Li B, Zhou X, Gai P. Liu J, et al. J Cancer Res Ther. 2019;15(2):426-436. doi: 10.4103/jcrt.JCRT_750_18. J Cancer Res Ther. 2019. PMID: 30964122 Free article.
AIMS AND METHODS: Retrospectively, this paper compared the differences of the Epstein-Barr virus (EBV)-encoded small RNAs (EBERs), protein expression and gene mutations of tumor suppressor gene p53 (TP53) in keratinized nasopharyngeal squamous cell carcino
AIMS AND METHODS: Retrospectively, this paper compared the differences of the Epstein-Barr virus (EBV)-encoded small RNAs (EBERs), protein e …
Transnasal photoimmunotherapy with cetuximab sarotalocan sodium: Outcomes on the local recurrence of nasopharyngeal squamous cell carcinoma.
Omura G, Honma Y, Matsumoto Y, Shinozaki T, Itoyama M, Eguchi K, Sakai T, Yokoyama K, Watanabe T, Ohara A, Kato K, Yoshimoto S. Omura G, et al. Auris Nasus Larynx. 2023 Aug;50(4):641-645. doi: 10.1016/j.anl.2022.06.004. Epub 2022 Jun 29. Auris Nasus Larynx. 2023. PMID: 35779979
HNC-PIT has been conditionally approved in Japan in September 2020 for the treatment of unresectable locally advanced or unresectable locoregionally recurrent HNC. However, its outcomes on the local recurrence of the nasopharyngeal squamous cell carcinoma
HNC-PIT has been conditionally approved in Japan in September 2020 for the treatment of unresectable locally advanced or unresectable locore …
Definitive radiotherapy for nasopharyngeal carcinoma in Japan: analysis of cases in the National Head and Neck Cancer Registry from 2011 to 2014.
Koide Y, Kodaira T, Kitayama M, Kawakita D, Kirita T, Yoshimoto S, Nakamizo M, Nibu KI. Koide Y, et al. Jpn J Clin Oncol. 2024 Jan 7;54(1):54-61. doi: 10.1093/jjco/hyad130. Jpn J Clin Oncol. 2024. PMID: 37781753
METHODS: A total of 741 patients diagnosed with primary nasopharyngeal carcinoma were screened from 2011 to 2014. The inclusion criteria were histologically proven nasopharyngeal squamous cell carcinoma, receiving definitive radiotherapy, and no distan …
METHODS: A total of 741 patients diagnosed with primary nasopharyngeal carcinoma were screened from 2011 to 2014. The inclusion criteria wer …
Impact of retropharyngeal lymph node metastasis in head and neck squamous cell carcinoma.
Gross ND, Ellingson TW, Wax MK, Cohen JI, Andersen PE. Gross ND, et al. Arch Otolaryngol Head Neck Surg. 2004 Feb;130(2):169-73. doi: 10.1001/archotol.130.2.169. Arch Otolaryngol Head Neck Surg. 2004. PMID: 14967745
OBJECTIVE: To better define the prognostic significance of metastatic retropharyngeal adenopathy in patients with non-nasopharyngeal squamous cell carcinoma of the head and neck. STUDY DESIGN: A retrospective cohort study of patients with non-nasoph
OBJECTIVE: To better define the prognostic significance of metastatic retropharyngeal adenopathy in patients with non-nasopharyngeal
14 results